IUPAC Name: | 2,3,4,4a,5,6,7,7a-octahydrocyclopenta[b][1,4]oxazine |
Description: | Octahydrocyclopenta[b]morpholine is used as a reactant in the preparation of novel 4-(substituted amino)-7H-pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors, useful in treating Parkinson's disease. |
Molecular Weight: | 127.2 |
Molecular Formula: | C7H13NO |
Canonical SMILES: | C1CC2C(C1)OCCN2 |
InChI: | InChI=1S/C7H13NO/c1-2-6-7(3-1)9-5-4-8-6/h6-8H,1-5H2 |
InChI Key: | FVHPPCBSLJVBQR-UHFFFAOYSA-N |
Solubility: | Chloroform (Slightly), Methanol (Slightly) |
Appearance: | Light Yellow to Yellow Oil |
Storage: | 4°C |
References: | Galatsis, P., et al. U.S. Pat. Appl. Publ. (2014), US 20140005183 A1 20140102.. |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Other Building Blocks
N-((4-Oxo-1-phenyl-4,7-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)methyl)acetamide
Customers Also Viewed
N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-2-naphthalenesulfonamide
Copyright © 2025 BOC Sciences. All rights reserved.
Our Products